491 related articles for article (PubMed ID: 19439326)
41. Serotonin depletion effects on the pilocarpine model of epilepsy.
Trindade-Filho EM; de Castro-Neto EF; de A Carvalho R; Lima E; Scorza FA; Amado D; Naffah-Mazzacoratti Mda G; Cavalheiro EA
Epilepsy Res; 2008 Dec; 82(2-3):194-9. PubMed ID: 18845420
[TBL] [Abstract][Full Text] [Related]
42. In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin.
Clinckers R; Gheuens S; Smolders I; Meurs A; Ebinger G; Michotte Y
Epilepsia; 2005 Jun; 46(6):828-36. PubMed ID: 15946324
[TBL] [Abstract][Full Text] [Related]
43. Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.
Okada M; Northup JK; Ozaki N; Russell JT; Linnoila M; Goldman D
Mol Psychiatry; 2004 Jan; 9(1):55-64. PubMed ID: 14699441
[TBL] [Abstract][Full Text] [Related]
44. Piperine protects epilepsy associated depression: a study on role of monoamines.
Pal A; Nayak S; Sahu PK; Swain T
Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1288-95. PubMed ID: 22195361
[TBL] [Abstract][Full Text] [Related]
45. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice.
Nonogaki K; Ohba Y; Sumii M; Oka Y
Biochem Biophys Res Commun; 2008 Jul; 372(1):186-90. PubMed ID: 18477467
[TBL] [Abstract][Full Text] [Related]
46. Serotonergic receptor upregulation in cerebral cortex and down regulation in brainstem of streptozotocin induced diabetic rats: antagonism by pyridoxine and insulin.
Abraham PM; Anju TR; Jayanarayanan S; Paulose CS
Neurosci Lett; 2010 Oct; 483(1):23-7. PubMed ID: 20655360
[TBL] [Abstract][Full Text] [Related]
47. Involvement of 5-HT₇ receptors in the pathogenesis of temporal lobe epilepsy.
Yang Z; Liu X; Yin Y; Sun S; Deng X
Eur J Pharmacol; 2012 Jun; 685(1-3):52-8. PubMed ID: 22543085
[TBL] [Abstract][Full Text] [Related]
48. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain.
Jyoti A; Sharma D
Neurotoxicology; 2006 Jul; 27(4):451-7. PubMed ID: 16500707
[TBL] [Abstract][Full Text] [Related]
49. Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats.
Hayashi A; Suzuki M; Sasamata M; Miyata K
J Pharm Pharmacol; 2004 Dec; 56(12):1551-6. PubMed ID: 15563762
[TBL] [Abstract][Full Text] [Related]
50. Motor map expansion in the pilocarpine model of temporal lobe epilepsy is dependent on seizure severity and rat strain.
Young NA; Vuong J; Ozen LJ; Flynn C; Teskey GC
Exp Neurol; 2009 Jun; 217(2):421-8. PubMed ID: 19361501
[TBL] [Abstract][Full Text] [Related]
51. Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis.
Skelin I; Yamane F; Diksic M
Neurochem Int; 2008 Dec; 53(6-8):236-43. PubMed ID: 18786747
[TBL] [Abstract][Full Text] [Related]
52. Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine.
Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
Neurosci Lett; 2005 Dec; 390(1):48-53. PubMed ID: 16139430
[TBL] [Abstract][Full Text] [Related]
53. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
[TBL] [Abstract][Full Text] [Related]
54. Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection.
Ung RV; Landry ES; Rouleau P; Lapointe NP; Rouillard C; Guertin PA
Eur J Neurosci; 2008 Dec; 28(11):2231-42. PubMed ID: 19019202
[TBL] [Abstract][Full Text] [Related]
55. Dual protective effect of Passiflora incarnata in epilepsy and associated post-ictal depression.
Singh B; Singh D; Goel RK
J Ethnopharmacol; 2012 Jan; 139(1):273-9. PubMed ID: 22107833
[TBL] [Abstract][Full Text] [Related]
56. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.
Giorgetti M; Tecott LH
Eur J Pharmacol; 2004 Mar; 488(1-3):1-9. PubMed ID: 15044029
[TBL] [Abstract][Full Text] [Related]
57. Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.
Andrews MD; Green MP; Allerton CM; Batchelor DV; Blagg J; Brown AD; Gordon DW; McMurray G; Millns DJ; Nichols CL; Watson L
Bioorg Med Chem Lett; 2009 Sep; 19(18):5346-50. PubMed ID: 19692241
[TBL] [Abstract][Full Text] [Related]
58. 5-HT2C receptor agonists as an innovative approach for psychiatric disorders.
Rosenzweig-Lipson S; Dunlop J; Marquis KL
Drug News Perspect; 2007 Nov; 20(9):565-71. PubMed ID: 18176661
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological and genetic interventions in serotonin (5-HT)(2C) receptors to alter drug abuse and dependence processes.
Filip M; Spampinato U; McCreary AC; Przegaliński E
Brain Res; 2012 Oct; 1476():132-53. PubMed ID: 22494568
[TBL] [Abstract][Full Text] [Related]
60. Improved neuroprotective effects by combining Bacopa monnieri and Rosmarinus officinalis supercritical CO2 extracts.
Ramachandran C; Quirin KW; Escalon E; Melnick SJ
J Evid Based Complementary Altern Med; 2014 Apr; 19(2):119-27. PubMed ID: 24647092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
